Bill Athenson
- Role
- Chief Executive Officer at Third Pole Therapeutics
- Location
- Lake Forest, IL, US
- LinkedIn followers
- 500 followers
About Bill Athenson
Seasoned healthcare executive experienced in mission focused investing with a record of…
Experience
Chief Executive Officer
Oct 2019 — Present
Third Pole Therapeutics is developing transformative cardio-pulmonary therapies capable of expanding access to life-saving treatments worldwide. Third Pole’s technology generates pure Nitric Oxide (iNO), a selective pulmonary vasodilator that is FDA approved for the treatment of hypoxic respiratory failure of the newborn. This innovative technology has the potential to provide clinicians with greater access to a life-saving treatment and may enable the worldwide use of iNO outside of critical care settings. The Company is aggressively expanding its leadership and development teams and forging high impact strategic partnerships to expedite the global launch of clinic-ready iNO therapy delivery systems to patients.
Education
Northwestern University - Kellogg School of Management
Master of Business Administration (M.B.A.), Marketing and Finance
1989 — 1991
Skills
- Fda
- Management
- Strategy
- Cross-Functional Team Leadership
- Strategic Planning
- Start-Ups
- Commercialization
- Business Development
- Medical Devices
- Market Development
- Hardware Diagnostics
- Product Launch
- Capital Equipment
- Lifesciences
- U.s. Food and Drug Administration (Fda)
- R&D
- Biotechnology
- Immunoassays
- Product Development
- Life Sciences
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.